OXYC Canadian Trademark Information
Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released and/or targeted targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for use in the treatment of attention deficit disorders, central nervous system disorders depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis. Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations.
Perfect for these industries
Words that describe this mark
drug delivery systems controlled timed release andor targeted release pharmaceutical compositions provided integral component pharmaceutical preparations drug delivery systems controlled timed released andor targeted targeted release pharmaceutical compositions nature oral solid dose tablets capsules
Abandonment Notice!
On Tuesday, May 3, 2016,
status on the OXYC
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Wednesday, August 27, 2014, a canadian trademark registration was filed for
OXYC by INTELLIPHARMACEUTICS CORP *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1691385.
The current status of this trademark filing is Interruption of proceeding.
The OXYC
trademark is filed in the description of
Drug delivery systems, namely controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations; drug delivery systems, namely controlled timed released and/or targeted targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations; pharmaceutical preparations incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, all for use in the treatment of attention deficit disorders, central nervous system disorders depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis.
,
Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.